연구성과로 돌아가기
2021 연구성과별 연구자 정보 (208 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Lee, Jeonghoon | Lee, J | 6 | Seoul Natl Univ Hosp, Seoul, South Korea | jhamilton@arrowheadpharma.com; | |||||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Lee, Jung Il | Lee, JI | 7 | Gangnam Severance Hosp, Seoul, South Korea | jhamilton@arrowheadpharma.com; | |||||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Kweon, Young Oh | Kweon, YO | 8 | Kyungpook Natl Univ, Daegu, South Korea | jhamilton@arrowheadpharma.com; | |||||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Weltman, Martin | Weltman, M | 9 | Nepean Hosp, Penrith, NSW, Australia | jhamilton@arrowheadpharma.com; | |||||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Harrison, Stephen | Harrison, S | 10 | Pinnacle Clin Res Ctr, San Antonio, TX USA | GON-3283-2022 | Harrison, Stephen | jhamilton@arrowheadpharma.com; | |||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Tetri, Brent | Tetri, B | 11 | St Louis Univ, Sch Med, St Louis, MO USA | jhamilton@arrowheadpharma.com; | |||||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Cusi, Kenneth | Cusi, K | 12 | Univ Florida, Gainesville, FL USA | ADV-2401-2022 | Cusi, Kenneth | jhamilton@arrowheadpharma.com; | |||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Loomba, Rohit | Loomba, R | 13 | UCSD, NAFLD Res Ctr, La Jolla, CA USA | AAE-7831-2019 | Loomba, Rohit | jhamilton@arrowheadpharma.com; | |||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Christianson, Dawn | Christianson, D | 14 | Arrowhead Pharmaceut Inc, Pasadena, CA USA | jhamilton@arrowheadpharma.com; | |||||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Rajicic, Natasa | Rajicic, N | 15 | Arrowhead Pharmaceut Inc, Pasadena, CA USA | jhamilton@arrowheadpharma.com; | |||||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | San Martin, Javier | San Martin, J | 16 | Arrowhead Pharmaceut Inc, Pasadena, CA USA | jhamilton@arrowheadpharma.com; | |||||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Hamilton, James | Hamilton, J | 17 | Arrowhead Pharmaceut Inc, Pasadena, CA USA | jhamilton@arrowheadpharma.com; | |||||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Mak, Lung Yi Loey | Mak, LYL | 18 | Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China | ABB-1599-2020 | Mak, Lung Yi (Loey) | jhamilton@arrowheadpharma.com; | |||
| ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | Yuen, Man-Fung | Yuen, MF | 19 | Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China | C-4466-2009 | Yuen, Richard Man Fung | jhamilton@arrowheadpharma.com; | |||
| ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH | Mak, Lung-Yi | Mak, LY | 1 | Univ Hong Kong, Med, Hong Kong, Peoples R China | ABB-1599-2020 | Mak, Lung Yi (Loey) |
페이지 이동: